The efficacy for IFNβ was considered to be due suppression of viral infections that are associated with relapses and to direct immunomodulatory effects that include reduction of pathogenic Th1 and Th17 CD4+ T cells, and to increases in IL-10 producing Treg cells (87). Here, IFNB1 is linked to viral infectious disease.